October 19, 2022 without regard to Supreme Court Ruling involvement of Illegal COVID Vaccine Mandates and not reviewing the comments and human rights legalities, and the steamrolling CDC genocide agenda… 🆘🆘🆘 ACIP decided that the COVID-19 vaccine should be added to VFC in a separate vote that took place Wednesday afternoon. This illegal early vote would counter any opposition comments and void scientific legal rhetoric— If you find the criminal gang mafia who approved illegal toxic Covid-19 non vaccines to be added to childhood vaccination schedules, please add to the comment section below so I can add the information to this ongoing article. Thank you. Who are the mystery people on CDC Independent 15 member panel that approved CDC votes to recommend vaccine for children ages? Looks like Supreme Court Ruling about Not legalizing COVID-19 Vaccine Mandates is being challenged by 15 independent people who voted to add COVID-19 Vaccinations to childhood Vaccination schedules! CDC to Vote on adding COVID-19 Immunization schedule for children in already deadly children’s vaccination schedule❤️‍🩹‼️

October 22, 2022 - S.D. Wells

World-class veteran bodybuilder Doug Brignole dies of “unknown causes” after getting Moderna Covid jab and advising the world to avoid all the anti-vax “fearmongers”

Who are the mystery people on CDC Independent 15 member panel that approved CDC votes to recommend vaccine for children ages?

October 19, 2022 without regard to Supreme Court Ruling involvement of Illegal COVID Vaccine Mandates and not reviewing the comments and human rights legalities, and the steamrolling CDC genocide agenda…

“ACIP decided that the COVID-19 vaccine should be added to VFC in a separate vote that took place Wednesday afternoon.”

VACCINE Published October 20, 2022 1:54pm EDT

CDC advisory committee votes to add COVID-19 vaccine to immunization schedules for children, adults

The vote was unanimous, with 15 in favor and none against

Ronn Blitzer By Ronn Blitzer | Fox News

Fox News Flash top headlines for October 20 Video

Fox News Flash top headlines for October 20

Fox News Flash top headlines are here. Check out what's clicking on Foxnews.com.

The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices on Thursday voted unanimously to approve the CDC’s new recommended immunization schedules for adults and children for 2023, which adds vaccination for COVID-19.

Special note: The numerous people listed cover about one year of services with CDC but not verified as members who voted to change the course of human history and increased genocide of children all ages subjected to massive toxic antigens like MRNA COVID-19 Vaccines.

CDC Web Archive

THIS WEB PAGE IS ARCHIVED FOR HISTORICAL PURPOSES AND IS NO LONGER BEING UPDATED. PLEASE GO TO CDC HOME OR USE THE A-Z INDEX OR SEARCH FOR MORE RECENT INFORMATION.

CDC Home

A-Z Index

Skip directly to site contentSkip directly to page optionsSkip directly to A-Z link

Advisory Committee on Immunization Practices (ACIP)

Section Navigation

ACIP Members August 2021- June 2022

August 23, 2020: Content on this page kept for historical reasons.

Printer friendly version of ACIP Members list pdf icon[9 pages]

The ACIP includes 15 voting members responsible for making vaccine recommendations. The Secretary of the U.S. Department of Health and Human Services (DHHS) selects these members following an application and nomination process. Fourteen of the members have expertise in vaccinology, immunology, pediatrics, internal medicine, nursing, family medicine, virology, public health, infectious diseases, and/or preventive medicine; one member is a consumer representative who provides perspectives on the social and community aspects of vaccination.

In addition to the 15 voting members, ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States, and 30 non-voting representatives of liaison organizations that bring related immunization expertise.

Members and representatives serve on the Committee voluntarily.

CHAIR

LEE, Grace M., MD, MPH

Associate Chief Medical Officer for Practice Innovation

Lucile Packard Children’s Hospital

Professor of Pediatrics, Stanford University School of Medicine

Stanford, CA

Term: 8/4/2021 – 6/30/2023

EXECUTIVE SECRETARY

COHN, Amanda, MD

Senior Advisor for Vaccines

National Center for Immunization and Respiratory Diseases

Centers for Disease Control and Prevention

Atlanta, GA

Members

AULT, Kevin A., MD, FACOG, FIDSA

Professor and Division Director

Department of Obstetrics and Gynecology

University of Kansas Medical Center

Kansas City, KS

Term: 10/26/2018 – 6/30/2022

BAHTA, Lynn, RN, MPH, CPH

Immunization Program Clinical Consultant

Infectious Disease, Epidemiology, Prevention & Control Division

Minnesota Department of Health

Saint Paul, Minnesota

Term: 7/1/2019 – 6/30/2023

BELL, Beth P., MD, MPH

Clinical Professor

Department of Global Health, School of Public Health

University of Washington

Seattle, WA

Term: 7/1/2019 – 6/30/2023

CHEN, Wilbur H., MD, MS, FACP, FIDSA

Professor of Medicine

Center for Vaccine Development and Global Health

University of Maryland School of Medicine

Baltimore, MD

Term: 12/23/2020 – 6/30/2024

DALEY, Matthew F., MD

Senior Investigator

Institute for Health Research

Kaiser Permanente Colorado

Aurora, CO

Term: 1/4/2021 – 6/30/2024

KOTTON, Camille Nelson, MD, FIDSA, FAST

Clinical Director, Transplant and Immunocompromised Host Infectious Diseases

Infectious Diseases Division, Massachusetts General Hospital

Associate Professor of Medicine, Harvard Medical School

Boston, MA

Term: 12/23/2020 – 6/30/2024

LONG, Sarah S., MD

Professor of Pediatrics

Drexel University College of Medicine

Section of Infectious Diseases

St. Christopher’s Hospital for Children

Philadelphia, Pennsylvania

Term: 12/24/2020 – 6/30/2024

MCNALLY, Veronica V., JD

President and CEO

Franny Strong Foundation

West Bloomfield, Michigan

Term: 10/31/2018 – 6/30/2022

POEHLING, Katherine A., MD, MPH

Professor of Pediatrics and Epidemiology and Prevention

Director, Pediatric Population Health

Department of Pediatrics

Wake Forest School of Medicine

Winston-Salem, NC

Term: 7/1/2019 – 6/30/2023

SÁNCHEZ, Pablo J., M.D.

Professor of Pediatrics

The Ohio State University – Nationwide Children’s Hospital

Divisions of Neonatal-Perinatal Medicine and Pediatric Infectious Diseases

Director, Clinical & Translational Research (Neonatology)

Center for Perinatal Research

The Research Institute at Nationwide Children’s Hospital

Columbus, Ohio

Term: 7/1/2019 – 6/30/2023

TALBOT, Helen Keipp, MD

Associate Professor of Medicine

Vanderbilt University

Nashville, TN

Term: 10/29/2018 – 6/30/2022

Ex Officio Members

Centers for Medicare and Medicaid Services (CMS)

HANCE, Mary Beth

Senior Policy Advisor

Division of Quality, Evaluations and Health Outcomes

Children and Adults Health Programs Group

Center for Medicaid, CHIP and Survey & Certification

Centers for Medicare and Medicaid Services

Baltimore, MD

Food and Drug Administration (FDA)

FINK, Doran, MD, PhD

Deputy Director, Clinical, Division of Vaccines and Related Products Applications

Office of Vaccines Research and Review

Center for Biologics Evaluation and Research

Food and Drug Administration

Silver Spring, MD

Health Resources and Services Administration (HRSA)

RUBIN, Mary, MD

Chief Medical Officer

Division of Injury Compensation Programs

Rockville, MD

Indian Health Service (IHS)

WEISER, Thomas, MD, MPH

Medical Epidemiologist

Portland Area Indian Health Service

Portland, OR

Office of Infectious Disease and HIV/AIDS Policy (OIDP)

KIM, David, MD, MA

Director, Division of Vaccines, OIDP

Office of the Assistant Secretary for Health

Department of Health and Human Services

Washington, DC

National Institutes of Health (NIH)

BEIGEL, John, M.D.

Associate Director for Clinical Research

Division of Microbiology and Infectious Diseases

National Institute of Allergy and Infectious Diseases (NIAID)

Bethesda, MD

Liaison Representatives

American Academy of Family Physicians (AAFP)

ROCKWELL, Pamela G., D.O.

Associate Professor, Department of Family Medicine,

University of Michigan Medical School

Medical Director, Dominos Farms Family Medicine

Ann Arbor, MI

American Academy of Pediatrics (AAP)

MALDONADO, Yvonne, MD

Senior Associate Dean for Faculty Development and Diversity

Professor of Pediatrics and Health Research and Policy

Chief, Division of Pediatric Infectious Diseases

Stanford University School of Medicine

Stanford, CA

American Academy of Pediatrics (AAP) Red Book Editor

KIMBERLIN, David, MD

Professor of Pediatrics

Division of Pediatric Infectious Diseases

The University of Alabama at Birmingham School of Medicine

Birmingham, AL

American Academy of Physician Assistants (AAPA)

LÉGER, Marie-Michèle, MPH, PA-C

Senior Director, Clinical and Health Affairs

American Academy of Physician Assistants

Alexandria, VA

American College Health Association (ACHA)

CHAI, Thevy S., MD

Director of Medical Services

Campus Health Services

University of North Carolina at Chapel Hill

Chapel Hill, NC

American College Health Association (ACHA) (alternate)

MCMULLEN, Sharon, RN, MPH, FACHA

she/her/hers

Assistant Vice President of Student & Campus Life for Health and Wellbeing

Cornell Health

Ithaca, NY

American College of Nurse Midwives (ACNM)

HAYES, Carol E., CNM, MN, MPH, FACNM

Adjunct Professor

Georgia State University School of Nursing

Atlanta, GA

American College of Nurse Midwives (ACNM) (alternate)

MEHARRY, Pamela M., PHD, CNM

Midwifery Educator, Human Resources for Health

In partnership with University of Rwanda and University of Illinois, Chicago

American College of Obstetricians and Gynecologists (ACOG)

ECKERT, Linda O., MD, FACOG

Professor, Department of Obstetrics & Gynecology

Adjunct Professor, Department of Global Health

University of Washington

Seattle, WA

American College of Physicians (ACP)

GOLDMAN, Jason M. MD, FACP

Affiliate Assistant Professor of Clinical Biomedical Science, Florida Atlantic University, Boca Raton, Florida

Private Practice

Coral Springs, FL

American Geriatrics Society (AGS)

SCHMADER, Kenneth, MD

Professor of Medicine-Geriatrics

Geriatrics Division Chief

Duke University and Durham VA Medical Centers

Durham, NC

America’s Health Insurance Plans (AHIP)

GLUCKMAN, Robert A., MD, MACP

Chief Medical Officer, Providence Health Plans

Beaverton, OR

American Immunization Registry Association (AIRA)

COYLE, Rebecca, MSEd

Executive Director, AIRA

Washington, DC

American Medical Association (AMA)

FRYHOFER, Sandra Adamson, MD

Adjunct Associate Professor of Medicine

Emory University School of Medicine

Atlanta, GA

American Nurses Association (ANA)

RITTLE, Charles (Chad), DNP, MPH, RN

Assistant Professor, Nursing Faculty

Chatham University, School of Health Sciences

Pittsburgh, PA

American Osteopathic Association (AOA)

GROGG, Stanley E., DO

Associate Dean/Professor of Pediatrics

Oklahoma State University-Center for Health Sciences

Tulsa, OK

American Pharmacists Association (APhA)

FOSTER, Stephan L., PharmD

CAPT (Ret) U.S.P.H.S.

Professor, College of Pharmacy

University of Tennessee Health Sciences Center

Memphis, TN

Association of Immunization Managers (AIM)

HOWELL, Molly, MPH

Immunization Program Manager

North Dakota Department of Health

Bismarck, ND

Association for Prevention Teaching and Research (APTR)

McKINNEY, W. Paul, MD

Professor and Associate Dean

University of Louisville School of Public Health and Information Sciences

Louisville, KY

Association of State and Territorial Health Officials (ASTHO)

SHAH, Nirav D., MD, JD

Director

Maine Center for Disease Control and Prevention

Augusta, ME

Biotechnology Industry Organization (BIO)

ARTHUR, Phyllis A., MBA

Senior Director, Vaccines, Immunotherapeutics and Diagnostics Policy

Washington, DC

Council of State and Territorial Epidemiologists (CSTE)

HAHN, Christine, MD

State Epidemiologist

Office of Epidemiology, Food Protection and Immunization

Idaho Department of Health and Welfare

Boise, ID

Council of State and Territorial Epidemiologists (CSTE) (alternate)

LETT, Susan, MD, MPH

Medical Director, Immunization Program

Division of Epidemiology and Immunization

Massachusetts Department of Public Health

Boston, MA

Canadian National Advisory Committee on Immunization (NACI)

QUACH, Caroline, MD, MSc

Pediatric Infectious Disease Specialist and Medical Microbiologist

Medical Lead, Infection Prevention and Control Unit

Medical Co-director – Laboratory Medicine, Optilab

Montreal-CHUM

Montreal, Québec, Canada

Infectious Diseases Society of America (IDSA)

BAKER, Carol J., MD

Professor of Pediatrics

Molecular Virology and Microbiology

Baylor College of Medicine

Houston, TX

International Society for Travel Medicine (ISTM)

BARNETT, Elizabeth D, MD

Professor of Pediatrics

Boston University School of Medicine

Boston, MA

National Association of County and City Health Officials (NACCHO)

ZAHN, Matthew, MD

Medical Director, Epidemiology

Orange County Health Care Agency

Santa Ana, CA

National Association of County and City Health Officials (NACCHO) (alternate)

DUCHIN, Jeffrey, MD

Health Officer and Chief, Communicable Disease Epidemiology and Immunization Section

Public Health – Seattle and King County

Professor in Medicine

Division of Allergy and Infectious Diseases

University of Washington School of Medicine and School of Public Health

Seattle, WA

National Association of Pediatric Nurse Practitioners (NAPNAP)

STINCHFIELD, Patricia A., RN, MS, CPNP

Director

Infectious Disease/Immunology/Infection Control

Children’s Hospitals and Clinics of Minnesota

St. Paul, MN

National Foundation for Infectious Diseases (NFID)

SCHAFFNER, William, MD

Chairman, Department of Preventive Medicine

Vanderbilt University School of Medicine

Nashville, TN

National Foundation for Infectious Diseases (NFID) (alternate)

DALTON, Marla, PE, CAE

Executive Director & CEO

National Foundation for Infectious Diseases (NFID)

Bethesda, MD

National Medical Association (NMA)

WHITLEY-WILLIAMS, Patricia, MD

Professor and Chair

University of Medicine and Dentistry of New Jersey

Robert Wood Johnson Medical School

New Brunswick, NJ

Pediatric Infectious Diseases Society (PIDS)

O’LEARY, Sean, MD, MPH

Associate Professor of Pediatrics

Pediatric Infectious Diseases

General Academic Pediatrics

Children’s Hospital Colorado

University of Colorado School of Medicine

Pediatric Infectious Diseases Society (PIDS) (alternate)

SAWYER, Mark H, MD

Professor of Clinical Pediatrics

University of California, San Diego School of Medicine

San Diego, CA

Pharmaceutical Research and Manufacturers of America (PhRMA)

ROBERTSON, Corey, MD, MPH

Senior Director, US Medical, Sanofi Pasteur

Swiftwater, PA

Society for Adolescent Health and Medicine (SAHM)

MIDDLEMAN, Amy B., MD, MSEd, MPH

Professor of Pediatrics

Chief, Section of Adolescent Medicine

University of Oklahoma Health Sciences Center

Oklahoma City, OK

Society for Healthcare Epidemiology of America (SHEA)

DREES, Marci, MD, MS

Chief Infection Prevention Officer & Hospital Epidemiologist

ChristianaCare

Wilmington, DE

Associate Professor of Medicine

Sidney Kimmel Medical College at Thomas Jefferson University

Philadelphia, PA

ABC NEWSMay 12, 2021
CDC panel votes to recommend vaccine for children ages 12 to 15
PHOTO: Registered Medical Assistant Melissa Dalton inoculates a teenager with the Pfizer vaccine against coronavirus disease after Georgia authorized the vaccine for children over 12 years old, at Dekalb Pediatric Center in Decatur, Ga., May 11, 2021.
2:16Christopher Aluka Berry/Reuters
CDC panel votes to recommend vaccine for children
By Sasha Pezenik, Michelle Stoddart
An independent panel of advisers to the Centers for Disease Control and Prevention voted Wednesday to recommend the Pfizer vaccine for use in children ages 12 to 15.
It marks a crucial milestone in the nation's push to tamp down COVID-19, with more shots in more Americans' arms helping pave the gradual path towards recovery and a return to normalcy. The Food and Drug Administration authorized the Pfizer vaccine for this age group Monday.
President Joe Biden hailed the decision in remarks on vaccinations Tuesday afternoon.
"My hope is that the parents will take advantage of the vaccine, and get their kids vaccinated," Biden said. "Let's remember that millions of 16- and 17-year-olds have been safely vaccinated and as more and more Americans are vaccinated, COVID-19 hospitalizations and death rates continue to fall."
PHOTO: President Joe Biden delivers remarks on Covid-19 response and the vaccination program, from the South Court Auditorium of the White House, Washington, May 12, 2021. Nicholas Kamm/AFP via Getty Images
President Joe Biden delivers remarks on Covid-19 response and the vaccination program, from the South Court Auditorium of the White House, Washington, May 12, 2021.
Getting adolescents vaccinated was part of the plan he laid out last week with a goal of getting 70% of Americans vaccinated by July 4.
Biden touted the safety of the vaccines and also the increasing convenience of access to doses for those who want them.
MORE: How to prepare for the coming wave of COVID child vaccinations: OPINION
"This new population is going to find the vaccine rollout fast and efficient," Biden said Tuesday. "As of tomorrow, more than 15,000 pharmacies across this country will be ready to vaccinate this age group."

CVS and Walgreens announced they would begin offering vaccinations for 12- to 15-year olds on Thursday.
Parental or legal guardian consent is required to receive the vaccine and children must be accompanied by an adult. Both companies encouraged people to make appointments.
PHOTO: Middle school student Elise Robinson waits with her mother, Anya Robinson, for her first coronavirus vaccination on May 12, 2021, in Decatur, Ga.Ron Harris/AP
Middle school student Elise Robinson waits with her mother, Anya Robinson, for her first coronavirus vaccination on May 12, 2021, in Decatur, Ga.
CDC Director Rochelle Walensky signed off on the recommendation later Wednesday, meaning that vaccinating children as young as 12 is now the official recommendation by the nation's top public health experts.
While health experts said it's rare for children to get very sick with COVID-19, there is still a risk. Also, officials hope adolescent vaccinations will help lower the risk of transmission, as classrooms and summer camps both look towards reopening.
MORE: FDA authorizes Pfizer vaccine for 12-15-year-olds
It comes as children now make up 22% of recent COVID-19 cases in the nation, according to the American Academy of Pediatrics and the Children's Hospital Association report.
PHOTO: Registered Medical Assistant Melissa Dalton inoculates a teenager with the Pfizer vaccine against coronavirus disease after Georgia authorized the vaccine for children over 12 years old, at Dekalb Pediatric Center in Decatur, Ga., May 11, 2021.Christopher Aluka Berry/Reuters
Registered Medical Assistant Melissa Dalton inoculates a teenager with the Pfizer vaccine against coronavirus disease after Georgia authorized the vaccine for children over 12 years old, at Dekalb Pediatric Center in Decatur, Ga., May 11, 2021.
Pfizer's clinical trials have shown their vaccine safe and 100% effective in children ages 12-15, aligning with the 95% efficacy among adult clinical trial participants. Among the more than 1,000 adolescents who received the vaccine, there were no cases of COVID-19 recorded; there were 16 cases among the 978 participants who got the placebo.
On safety, clinical evidence showed no current safety concerns for these children receiving this two-dose vaccine, with side effects similar to those observed in adults -- like a sore arm at the injection site, fatigue and headache, which should stop within a few days of getting the shot.
Children who are fully vaccinated would be able to follow the updated guidance for vaccinated people from the CDC. That includes not having to wear masks outdoors unless in a crowded venue and not having to quarantine if there is a known exposure.

https://worldcouncilforhealth.org/news/statements/cdc-covid-19-vaccines-on-childhood-vaccine-schedule/

CDC to Vote on adding COVID-19 Immunization schedule for children in already deadly children’s vaccination schedule❤️‍🩹‼️

Call to Action: CDC Advisory Committee Voting to Add Covid-19 mRNA Injections to Childhood Vaccine Schedule

ByWorld Council for HealthOctober 18, 2022

Share this

The US Centers for Disease Control and Prevention (CDC) Committee on Immunization Practices (ACIP) is scheduled to meet this week on October 19-20. A Vaccines for Children (VFC) vote on adding the Covid-19 vaccines to the CDC Childhood Immunization Schedule is on the agenda.

More than enough evidence exists showing that these injections are neither safe nor effective. Not only do they not belong on the routine childhood immunization schedule, they should not be given to children at all. Please see the WCH Pharmacovigilance Report for further details.

If these shots are successfully added to the childhood vaccine schedule in the US, Pfizer and Moderna will further escape product liability.

The CDC is now accepting comments from the public on meeting agenda items. We encourage everyone to voice their opinion and to share data with the ACIP ahead of this important vote.

Public comments are due by Thursday, October 20. Use this form to submit yours individually, as an organization, or anonymously.

As of the writing of this statement, more than 350 comments have already been recorded and can be viewed here.

In addition to submitting comments, ACIP committee members can be reached by phone.

Below you will find examples of letters sent in the UK in an effort to inform elected officials of the reality of these injections. We invite you to use use language from these letters and the data in them to help inform your messages to the ACIP.

The following is a letter sent to the Secretary of State for Health & Social Care from the Children’s Covid Vaccine Advisory Council (CCVAC):

We, the undersigned health professionals and scientists, call upon you urgently to pause the covid19 vaccine rollout for healthy children, while a thorough and independent safety review is undertaken. We have between us written numerous letters to your predecessors, regarding both the safety and necessity of these mRNA products in children. We would urge you to consider very carefully the role of vaccination in ever younger and younger children against SARS-CoV-2, despite the gradual but significant reducing virulence of successive variants, the increasing evidence of rapidly waning vaccine efficacy, the increasing concerns over long-term vaccine harms, and the knowledge that the vast majority of this young age group have already been exposed to SARS-CoV-2 repeatedly and have demonstrably effective immunity. Thus, the balance of benefit and risk which supported the rollout of mRNA vaccines to the elderly and vulnerable in 2021, is totally inappropriate for children in 2022.

Below are links to all the letters we have written to the regulators over the past year. The detailed questions contained, have never been properly addressed. Legal challenges are also in progress.

You may be aware that members of the Pandemic Response All Party Parliamentary Group have also written regarding increased all-cause mortality in 15-19-year-old males, again with no proper answer. https://dailysceptic.org/2022/01/08/end-covid-vaccination-of-children-because-the-risksoutweigh-the-benefits-government-told-by-mps-and-scientists/ The health of the nation’s children is of paramount concern and must surely be a high priority for an incoming Minister. We entreat you to apply the precautionary principle to the use of these products which still have no long-term safety data for children. Pausing the rollout would cost nothing.

The following is a letter sent to the Chief Executive of the UKHSA from HART (Health Advisory & Recovery Team):

We, the undersigned, are writing to express our deep concern at the guidance regarding further mRNA vaccination after any episode of myocarditis, as detailed in the UKHSA guidance for healthcare professionals.

Myocarditis severity has been downplayed:

The majority of patients with vaccine-associated myocarditis present with chest pain. This may be misinterpreted, by either the patient or doctor, as musculoskeletal pain, which is a recognised non-serious side effect of these products and cardiac pathology could be missed. Any patient presenting with chest pain should be assessed immediately in hospital as this may be life-threatening.

During the covid pandemic, anyone admitted to hospital with a positive test result was considered to have severe Covid-19. With myocarditis, every patient presenting with cardiac symptoms needs hospital assessment including ECGs, blood troponin levels and echocardiograms. This would therefore not fit the definition of a mild illness. A recent BMJ reviewquotes “Most people were admitted to hospital (≥84%) for a short duration (two to four days).” The review further quotes, “persistent echocardiogram abnormalities, as well as ongoing symptoms or a need for drug treatments or restriction from activities in >50% of patients”. Where cardiac MRI scans have been performed, 89% of patientshave shown Late Gadolinium Enhancement (LGE), which is known to be a predictor of a bad prognosis. Inflammation of the heart can lead to fibrosis and other complications such as arrhythmias and death. Left undiagnosed and therefore untreated, there is also a real risk of silent left ventricular dysfunction. Myocarditis should be considered far from being a mild illness.

The long term prognosis for post-vaccination myocarditis is also uncertain but early follow-up studies in children have shown two-thirds had persistent changes on cardiac MRI scans 3-8 months later, despite clinical improvement. A detailed US FDA advisory committee report from late 2021, showed that 40% of affected adolescents were still symptomatic at 3 month follow-up and 50% were still restricting their physical activity. Viral myocarditis can have serious late consequences with an approximately 20% six-year mortality. In the absence of appropriate long-term follow-up, it is reckless to assume that vaccine-associated myocarditis has a milder outcome.

It is therefore concerning that the UKHSA guidance contains advice such as:

Myocarditis incidence has been underplayed: Quoted risk of vaccine-associated myocarditis varies widely, with younger age and male sex being the two biggest risk factors and the vast majority of studies have shown a greater risk after a second dose. In Hong Kong, where specific information about myocarditis is given to all vaccinees, 1 in 2680 adolescent boys developed myocarditis after their second dose of Pfizer. A change in policy to a single dosage for this age-group, was estimated to have saved several cases. For boys aged 12-17, post-vaccine-myocarditis exceeds rates of hospitalisation for Covid-19 itself. It is also concerning that there has been no serious attempt to prospectively study the incidence of myocarditis. A prospective study from the US military, found that myocarditis post smallpox vaccination was 200-fold higher than background rates, compared with 7.5 x expected when using routine self-reporting. Blood testing post-vaccination elucidated asymptomatic cases at a further 6-fold higher rate. A small prospective study of secondary school-children in Thailand, using diary cards and blood troponins on day 3 and day 7, showed 29% with a potential cardiac symptom and 18% with abnormal ECGs. This is only a preprint but needs replicating before sweeping assertions of safety can be made.

Cumulative risk:

In most series, myocarditis has occurred after the second dose, yet government guidancesuggests patients who have suffered with myocarditis following initial vaccination, may still undergo further vaccinations:

“If there is no evidence of ongoing myocarditis, they can be offered vaccination with the Pfizer (Cominarty) vaccine from 12 weeks after their last dose if further doses are due. If there is evidence of ongoing effects of acute or subacute myocarditis, then an individual risk benefit assessment should be undertaken”

None of the vaccine trials included patients with a past history of myocarditis and we are aware of no data to support this advice. Giving a Covid-19 vaccine to someone with a past history of myocarditis of any cause, would require a thorough assessment and individual discussion of benefit and risk. Any episode of post-vaccination myocarditis should be seen as an absolute contraindication to receiving any further doses, as the risk of this serious cardiac condition is known to increase after the second dose. The UKHSA has acknowledged the total absence of long-term follow up following vaccine-associated myocarditis. Continuing with the policy outlined above is therefore reckless.

Actions required:

The following is a letter sent by the CCVAC to the Prime Minister of the UK:

Dear Prime Minister,

Re: Covid-19 Vaccines for Children

Firstly, congratulations on becoming our new Prime Minister.

You will no doubt have many pressing matters as you take up office. But what can be more important than the health and well-being of the nation’s children?

We, the undersigned health professionals and scientists, have huge concerns about the safety and necessity of Covid-19 vaccines for children, for reasons detailed in the linked letters below. We call upon you, urgently, to pause the Covid-19 vaccine rollout for healthy children, while a thorough and independent safety review is undertaken.

Between us, we have written numerous letters to the regulators, copied to your predecessor, regarding use of these mRNA products in children. We strongly urge you to reconsider their deployment for the following reasons. Covid-19 was always a much milder illness in children, with around a 1 in 2,000,000 risk of death for otherwise healthy children. Successive variants have become less virulent, reducing the risk still further. In addition, there is considerable evidence of rapidly waning vaccine efficacy, and increasing concerns over immediate vaccines injuries (such as myocarditis with its known potential for severe and possibly permanent cardiac damage). There is still a total lack of long-term safety data and the worrying rise in excess non-Covid deaths in young males aged 15-19 years has yet to be explained. Lastly, the vast majority of children have already been exposed to SARS-CoV-2 repeatedly and have achieved demonstrably effective immunity, which is far superior to vaccine-induced immunity.

In short, the balance of benefit and risk, used to support the rollout of mRNA vaccines to the elderly and vulnerable in 2021, is totally inappropriate and inapplicable for children in 2022.

Below are links to all the fully referenced letters we have written to the MHRA, the JCVI and the CMOs over the past year. The detailed questions posed have never been properly addressed by these regulators. Groups of health professionals from around the world have similar concerns and indeed some countries have already paused children’s Covid-19 vaccines, particularly for those who have already had SARS-CoV-2 infection. The Danish Minister of Health recently declared that vaccinating children had been a mistake and has withdrawn it for healthy children.

You may be aware that members of the Pandemic Response All Party Parliamentary Group also wrote to the JCVI in January 2022, regarding the documented increase in all-cause mortality in 15-19-year-old males, again with no satisfactory reply given to address their concerns.

The health of the nation’s children is of paramount concern and must surely be a high priority for an incoming Prime Minister. You will no doubt be aware of Sir Christopher Chope’s tireless work on a Covid-19 Vaccine Damage Bill, pushing for proper and fair compensation for thousands of vaccine-damaged adults. You cannot allow the risk of Covid-19 vaccine injuries in children, who stand to gain zero benefit from vaccination due to the overwhelming majority having already been infected, and who have therefore already acquired natural immunity.

We entreat you to apply the precautionary principle to the use of these products, which still have no long-term safety data and remain in Phase 3 clinical trials. The evidence of damage that this rushed policy is causing for children mounts daily.

In addition to concerns about the physical risk to children posed by these mRNA products, we would also remind you of the acknowledged and significant psychological and educational damage to children which resulted from the school closures and masking requirements implemented by your predecessor. We would ask that, as a matter of urgency, you make clear that school closures and masking of schoolchildren will not be repeated under your watch.

At the beginning of your term as Prime Minister, you now have a critical opportunity to prevent avoidable damage to children, and the inevitable outcry and backlash that will follow, by pausing the rollout with immediate effect, as well as bringing to an end all harmful covid restrictions in schools. This is a risk-free action. Until then, the political and health risks of these damaging policies will only escalate.

We eagerly await your response.

Wishing you well in the challenging job you have ahead.

Best Beautiful Books and Journals In The World in the Little House of Miracles Books and Journals many of which are to be found at Barnes and Noble https://www.barnesandnoble.com . Find Books On YouTube Too

Search This Blog

Kids World Plus

October 19, 2022 without regard to Supreme Court Ruling involvement of Illegal COVID Vaccine Mandates and not reviewing the comments and human rights legalities, and the steamrolling CDC genocide agenda…

“ACIP decided that the COVID-19 vaccine should be added to VFC in a separate vote that took place Wednesday afternoon.”

Special note: The numerous people listed cover about one year of services with CDC but not verified as members who voted to change the course of human history and increased genocide of children all ages subjected to massive toxic antigens like MRNA COVID-19 Vaccines.

CDC to Vote on adding COVID-19 Immunization schedule for children in already deadly children’s vaccination schedule❤️‍🩹‼️

Call to Action: CDC Advisory Committee Voting to Add Covid-19 mRNA Injections to Childhood Vaccine Schedule

Popular Posts

Fact checko! Kamala Harris says 18-24 year olds are 'stupid'